Reach Us +1-218-451-2974


Investigation Of Expression Patterns Of Neurological Proteins In Serum And Cerebrospinal Fluid Of Patients Suffering From Neurodegenerative Disorders | 101951
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Investigation of expression patterns of neurological proteins in serum and cerebrospinal fluid of patients suffering from neurodegenerative disorders

13th Annual Conference on Dementia and Alzheimers Disease

Ghulam Md Ashraf and Asma Perveen

King Fahd Center for Medical Research-King Abdulaziz University, Saudi ArabiaGlocal University, India

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460-C8-057

Recent researches have shown neurological proteins to exhibit altered expression in patients suffering from Neuro Degenerative patients (NDDs) like Alzheimer???s Disease (AD), Parkinson???s Disorder (PD), Vascular Dementia (VaD) and Amyotrophic Lateral Sclerosis (ALS). Serum and Cerebro Spinal Fluid (CSF) of various NDD patients were collected and the expression pattern of Galectins (Gal-1, Gal-3 and Gal-9) and Matrix Metalloproteinases (MMP-1, MMP-3 and MMP-9) was investigated. Quantitative ELISA measured the concentration of these proteins and a comparative analysis using other tools was done to understand their expression pattern. The findings of this work provided a definitive pattern of expression of Gals and MMPs in NDDs, which in turn proclaim their role as potential biomarkers to monitor the progression of the NDDs. These insights will in turn help in designing new and more promising therapeutics strategies for the NDDs.

Ghulam Md Ashraf is currently working as a Associate Professor in King Fahd Medical Research Centre, King Abdulaziz University. And he is his field of expertise are Biochemistry and Neurology. He is also designated as the associate editor in Frontiers in Aging Neuroscience.